Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 23 04:00PM ET
585.03
Dollar change
-5.77
Percentage change
-0.98
%
IndexS&P 500 P/E37.53 EPS (ttm)15.59 Insider Own0.19% Shs Outstand386.65M Perf Week-2.03%
Market Cap223.32B Forward P/E23.99 EPS next Y24.39 Insider Trans-19.75% Shs Float381.00M Perf Month1.32%
Income6.03B PEG5.66 EPS next Q5.12 Inst Own90.78% Short Float0.73% Perf Quarter3.60%
Sales42.49B P/S5.26 EPS this Y0.69% Inst Trans0.05% Short Ratio2.05 Perf Half Y21.28%
Book/sh119.24 P/B4.91 EPS next Y12.39% ROA6.29% Short Interest2.77M Perf Year11.41%
Cash/sh19.01 P/C30.77 EPS next 5Y6.63% ROE13.75% 52W Range415.60 - 603.82 Perf YTD10.22%
Dividend Est.1.50 (0.26%) P/FCF29.54 EPS past 5Y16.37% ROI7.87% 52W High-3.11% Beta0.80
Dividend TTM1.44 (0.25%) Quick Ratio1.33 Sales past 5Y12.53% Gross Margin39.47% 52W Low40.77% ATR (14)9.36
Dividend Ex-DateMar 14, 2024 Current Ratio1.70 EPS Y/Y TTM1.48% Oper. Margin17.58% RSI (14)52.58 Volatility1.29% 1.51%
Employees122000 Debt/Eq0.78 Sales Y/Y TTM-3.00% Profit Margin14.20% Recom1.75 Target Price625.46
Option/ShortYes / Yes LT Debt/Eq0.68 EPS Q/Q4.10% Payout9.06% Rel Volume0.87 Prev Close590.80
Sales Surprise1.87% EPS Surprise8.52% Sales Q/Q-3.41% EarningsApr 24 BMO Avg Volume1.35M Price585.03
SMA200.41% SMA501.46% SMA2009.72% Trades Volume1,170,036 Change-0.98%
Date Action Analyst Rating Change Price Target Change
Mar-18-24Resumed Citigroup Neutral $620
Jan-24-24Downgrade Barclays Overweight → Equal Weight $475 → $555
Jan-08-24Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23Initiated HSBC Securities Buy $610
Dec-13-23Initiated Wolfe Research Outperform $575
Oct-26-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23Upgrade Wells Fargo Underweight → Equal Weight $52 → $475
Sep-28-23Initiated Bernstein Outperform $603
Sep-06-23Resumed Citigroup Buy $625
Jul-19-23Reiterated Robert W. Baird Outperform $670 → $664
May-22-24 05:25PM
02:27PM
10:48AM
May-16-24 08:49AM
May-14-24 08:00AM
08:15AM Loading…
May-10-24 08:15AM
07:10AM
May-09-24 03:45PM
May-07-24 12:45PM
08:00AM
07:45AM
May-06-24 08:48AM
May-04-24 01:02AM
May-03-24 04:21AM
May-02-24 04:49PM
11:24AM Loading…
May-01-24 11:24AM
10:58AM
08:00AM
Apr-29-24 04:46PM
02:35PM
10:38AM
06:45AM
Apr-26-24 08:17AM
Apr-25-24 12:50PM
03:03AM
Apr-24-24 10:41PM
02:15PM
02:15PM
12:38PM
11:54AM
11:17AM Loading…
11:17AM
11:03AM
10:54AM
09:30AM
07:31AM
07:11AM
06:46AM
06:06AM
06:05AM
06:00AM
04:01AM
Apr-23-24 06:59AM
Apr-22-24 11:09AM
Apr-21-24 07:00AM
Apr-20-24 09:16AM
Apr-19-24 09:15AM
07:53AM
Apr-18-24 04:27PM
Apr-16-24 08:00AM
Apr-15-24 12:58PM
Apr-13-24 10:02AM
Apr-10-24 01:22PM
Apr-09-24 08:34AM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
Apr-02-24 06:15PM
08:36AM
08:00AM
08:00AM
Mar-28-24 02:36PM
02:10PM
02:07PM
08:01AM
Mar-27-24 06:00PM
Mar-26-24 06:15PM
08:02AM
Mar-22-24 09:41AM
Mar-21-24 10:25AM
02:53AM
Mar-20-24 06:00PM
06:29AM
Mar-19-24 08:00AM
Mar-18-24 06:15PM
Mar-17-24 05:47PM
Mar-14-24 12:00PM
09:38AM
09:00AM
Mar-12-24 06:00PM
09:09AM
Mar-11-24 03:04PM
10:20AM
Mar-06-24 06:00PM
02:45PM
Mar-05-24 06:00AM
Mar-01-24 11:30AM
09:00AM
08:00AM
Feb-29-24 09:30PM
06:00PM
03:04PM
Feb-28-24 08:00AM
Feb-26-24 01:19PM
Feb-23-24 12:02AM
Feb-21-24 05:00PM
Feb-20-24 06:00AM
Feb-19-24 10:55AM
Feb-17-24 01:29PM
Feb-15-24 04:13PM
06:11AM
Feb-14-24 10:01AM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagarde MichelExecutive Vice President & COOMay 14 '24Option Exercise105.1720,0002,103,40038,134May 15 04:16 PM
Lagarde MichelExecutive Vice President & COOMay 14 '24Sale590.0520,00011,801,00018,134May 15 04:16 PM
Williamson StephenSr. VP and CFOMay 13 '24Option Exercise210.6821,9254,619,15958,407May 15 04:14 PM
Williamson StephenSr. VP and CFOMay 13 '24Sale591.2721,92512,963,59536,482May 15 04:14 PM
CASPER MARC NChairman & CEOMay 01 '24Option Exercise190.5910,0001,905,900133,816May 02 04:19 PM
CASPER MARC NChairman & CEOMay 01 '24Sale573.7410,0005,737,356123,816May 02 04:19 PM
CASPER MARC NChairman & CEOApr 30 '24Option Exercise190.5910,0001,905,900133,816May 01 04:35 PM
CASPER MARC NChairman & CEOApr 30 '24Sale572.4110,0005,724,147123,816May 01 04:35 PM
CASPER MARC NChairman & CEOApr 29 '24Option Exercise190.5910,0001,905,900133,816May 01 04:35 PM
CASPER MARC NChairman & CEOApr 29 '24Sale575.9410,0005,759,384123,816May 01 04:35 PM
Boxer Michael ASVP and General CounselApr 26 '24Option Exercise210.682,000421,36015,083Apr 29 04:43 PM
Boxer Michael ASVP and General CounselApr 26 '24Sale567.942,0001,135,88013,083Apr 29 04:43 PM
CASPER MARC NChairman & CEOMar 13 '24Option Exercise190.5910,0001,905,900133,816Mar 14 04:03 PM
CASPER MARC NChairman & CEOMar 13 '24Sale594.5810,0005,945,759123,816Mar 14 04:03 PM
Britt Lisa P.Sr. VP and Chief HR OfficerMar 12 '24Option Exercise198.8514,3452,852,54525,768Mar 13 04:31 PM
CASPER MARC NChairman & CEOMar 12 '24Option Exercise190.5910,0001,905,900133,816Mar 13 05:24 PM
Britt Lisa P.Sr. VP and Chief HR OfficerMar 12 '24Sale598.9014,3458,591,22017,323Mar 13 04:31 PM
CASPER MARC NChairman & CEOMar 12 '24Sale597.9810,0005,979,758123,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOMar 11 '24Option Exercise190.5910,0001,905,900135,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOMar 11 '24Sale595.3610,0005,953,598125,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOFeb 29 '24Option Exercise190.5910,0001,905,900135,816Mar 04 04:36 PM
CASPER MARC NChairman & CEOFeb 29 '24Sale571.0810,0005,710,818125,816Mar 04 04:36 PM
CASPER MARC NChairman & CEOFeb 28 '24Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 28 '24Sale570.1810,0005,701,759128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27 '24Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27 '24Sale564.7210,0005,647,196128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 15 '24Sale550.625,5473,054,29043,608Feb 20 04:51 PM
Spar Debora LDirectorFeb 12 '24Sale546.9716489,7031,207Feb 14 04:36 PM
Boxer Michael ASVP and General CounselFeb 07 '24Option Exercise192.9814,5662,810,94727,467Feb 08 04:53 PM
Boxer Michael ASVP and General CounselFeb 07 '24Sale562.0014,5668,186,09212,901Feb 08 04:53 PM
CASPER MARC NChairman & CEOFeb 07 '24Sale555.6310,0005,556,28749,155Feb 08 04:51 PM
CASPER MARC NChairman & CEONov 07 '23Option Exercise157.681,600252,288132,775Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 07 '23Sale460.251,600736,404131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06 '23Option Exercise157.6810,0001,576,800141,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06 '23Sale454.4110,0004,544,053131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 03 '23Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 03 '23Sale456.1510,0004,561,459131,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02 '23Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02 '23Sale445.4910,0004,454,880131,175Nov 06 04:34 PM
Pettiti GianlucaExecutive Vice PresidentAug 30 '23Option Exercise253.993,000761,97020,556Aug 31 04:15 PM
Pettiti GianlucaExecutive Vice PresidentAug 30 '23Sale557.773,0001,673,31017,556Aug 31 04:15 PM
CASPER MARC NChairman & CEOAug 08 '23Option Exercise157.681,600252,288136,930Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 08 '23Sale550.601,600880,960135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07 '23Option Exercise157.6810,0001,576,800145,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07 '23Sale551.9410,0005,519,370135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 04 '23Option Exercise157.6810,0001,576,800145,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 04 '23Sale550.3310,0005,503,317135,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03 '23Option Exercise157.6810,0001,576,800151,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03 '23Sale549.0010,0005,490,050141,330Aug 07 04:05 PM
Williamson StephenSr. VP and CFOAug 01 '23Option Exercise190.5914,1002,687,31941,493Aug 02 04:33 PM
Williamson StephenSr. VP and CFOAug 01 '23Sale550.0014,1007,755,00027,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31 '23Option Exercise190.5915,0002,858,85042,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31 '23Sale557.4215,0008,361,30027,393Aug 02 04:33 PM
Boxer Michael ASVP and General CounselJun 26 '23Buy526.1542,10513,101Oct 06 04:23 PM